Antares Pharma: Halozyme Commences Tender Offer for All Outstanding Shares of Common Stock of Antares Pharma
Halozyme Therapeutics Inc. announced that the company is commencing, through wholly owned subsidiary Atlas Merger Sub Inc., a cash tender offer to purchase all outstanding shares of common stock of Antares Pharma Inc. for $5.60 per share in cash.
Read full article »
Antares Pharma is a New Jersey-based pharmaceutical company that develops and commercializes novel therapeutic products for the treatment of central nervous system disorders.
Read more